PeptideStack
5.2kquestions
20kanswers
220users

Is ERP worth the price difference against Shanghai Sigma-Audley on measured results?

Asked 27 Apr 2026Modified 3 months agoViewed 5.4k times
18

Conditions: ERP · Shanghai Sigma-Audley.

Both of these get recommended confidently by different people, which suggests neither is obviously right.

My constraints are cost, measurement resolution and how much handling I am prepared to do — in roughly that order.

Is there a defensible reason to prefer one, or is this a coin flip?

vendor-comparison
vendor-comparison

Side-by-side comparison of suppliers on measurable axes - independently confirmed purity and content, lead time, cold-chain handling,…

388 questionscost-analysis
cost-analysis

Cost arithmetic done honestly: cost per milligram after dead-space loss, list versus net price, comparing a multi-dose vial to a fixed-dose pen,…

260 questionsbatch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

910 questions
shareeditfollowflag
SK
askeds_kalniete57k3827 Apr 2026
Same question before my first order, and the small-order-then-test route worked. – two_point_four 8 months ago
8Do you have a certificate in front of you, or are you asking before requesting one? – Dr_Bram_Verhoeven 6 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 5.4k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.